|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
Approximately 25% of all reported medication errors result from some kind of name confusion.
The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.
Medication errors are more common among seriously ill patients than with those with minor conditions.
Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.